Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Cannabinoid CB1 receptor | Starlite/ChEMBL | References |
Homo sapiens | cannabinoid receptor 2 (macrophage) | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 1670000 nM | The effective concentration using [35S]-GTP-gammaS binding assay in rat membranes | ChEMBL. | 12061874 |
Emax (functional) | = -76.5 | Maximum concentration based on [35S]-GTP-gammaS binding assay in rat membranes | ChEMBL. | 12061874 |
Inhibition (binding) | = 69 % | Evaluated for binding affinity of the compound towards human Cannabinoid receptor 1 at a concentration of 20 microM | ChEMBL. | 14980654 |
Inhibition (binding) | = 69 % | Evaluated for binding affinity of the compound towards human Cannabinoid receptor 1 at a concentration of 20 microM | ChEMBL. | 14980654 |
Ki (binding) | = 343 nM | Binding affinity in a competition assay by displacement of [3H]- SR-141,716 from Cannabinoid receptor 1 in rat whole brain membrane preparation | ChEMBL. | 12061874 |
Ki (binding) | = 343 nM | Binding affinity in a competition assay by displacement of [3H]- SR-141,716 from Cannabinoid receptor 1 in rat whole brain membrane preparation | ChEMBL. | 12061874 |
Ki (binding) | = 385 nM | Binding affinity in a competition assay by displacement of [3H]- CP 55 940 from Cannabinoid receptor 1 in rat whole brain membrane preparation | ChEMBL. | 12061874 |
Ki (binding) | = 385 nM | Binding affinity in a competition assay by displacement of [3H]- CP 55 940 from Cannabinoid receptor 1 in rat whole brain membrane preparation | ChEMBL. | 12061874 |
Ki (binding) | = 4270 nM | Binding affinity at cannabinoid receptor 2 in a competition assay with [3H]-CP- 55 940 as radioligand | ChEMBL. | 12061874 |
Ki (binding) | = 4270 nM | Binding affinity at cannabinoid receptor 2 in a competition assay with [3H]-CP- 55 940 as radioligand | ChEMBL. | 12061874 |
Selectivity (binding) | = 11 | Selectivity measured as CB2/CB1 | ChEMBL. | 12061874 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.